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Leishmania major-Specific B Cells Are Necessary for Th2
Cell Development and Susceptibility to L. major LV39 in
BALB/c Mice1
Catherine Ronet,2*† Heike Voigt,2*† Hayo Himmelrich,*† Marie-Agne`s Doucey,3†
Yazmin Hauyon-La Torre,*† Me´lanie Revaz-Breton,*† Fabienne Tacchini-Cottier,*†
Claude Bron,† Jacques Louis,‡ and Pascal Launois4*†
B lymphocytes are considered to play a minimal role in host defense against Leishmania major. In this study, the contribution of
B cells to susceptibility to infection with different strains of L. major was investigated in BALB/c mice lacking mature B cells due
to the disruption of the IgM transmembrane domain (!MT). Whereas BALB/c !MT remained susceptible to infection with L.
major IR173 and IR75, they were partially resistant to infection with L. major LV39. Adoptive transfer of naive B cells into BALB/c
!MT mice before infection restored susceptibility to infection with L. major LV39, demonstrating a role for B cells in susceptibility
to infection with this parasite. In contrast, adoptive transfer of B cells that express an IgM/IgD specific for hen egg lysozyme
(HEL), an irrelevant Ag, did not restore disease progression in BALB/c !MT mice infected with L. major LV39. This finding was
likely due to the inability of HEL Tg B cells to internalize and present Leishmania Ags to specific T cells. Furthermore, specific
Ig did not contribute to disease progression as assessed by transfer of immune serum in BALB/c !MT mice. These data suggest
that direct Ag presentation by specific B cells and not Ig effector functions is involved in susceptibility of BALB/c mice to infection
with L. major LV39. The Journal of Immunology, 2008, 180: 4825–4835.
T he CD4! T cells recognize foreign peptides in associationwith MHC class II molecules at the surface of the APCs.Whereas professional APCs, i.e., macrophages, dendritic
cells (DCs),5 and B cells, are capable of sensitizing T cells, the
respective role of an individual subset of APCs in a particular T
cell response is yet unclear. Although DCs are clearly the APC
involved in primary T cell response, there is some evidence that B
cells are important for CD4! T cell responses, but their role in
either initiation or maintenance of such responses is not well
established.
In vitro, B cells are able to stimulate CD4! T cells (1–5);
however, a differential responsiveness of CD4! Th1 and Th2
clones was demonstrated depending on the nature of the APC.
Although purified B cells stimulate optimal proliferation of Th2
cells, adherent cells stimulate proliferation of Th1 cells (6). In
vivo, mice rendered deficient in B cells by administration of
anti-! chain Abs do not mount a T cell proliferative response in
lymph node (LN) cells (7–9), a priming defect reversed by
adoptive transfer of B cells before antigenic challenge (7, 9).
However, using mice genetically deficient in B cells, the role of
B cells as APCs is controversial. In B cell-deficient mice gen-
erated by disruption of the IgM transmembrane domain (!MT
mice), T cell proliferation and cytokine production to soluble
Ags, such as keyhole limpet hemocyanin, purified protein de-
rivative, or to deaggregated human gammaglobulins were iden-
tical with proliferation and production found in normal control
mice (10, 11). In contrast, primed CD4! T cells from B cell-
deficient mice generated by disruption of the Jh segment of the
Ig H chain (JHD) were unable to produce IL-4 and to provide T
cell help for Ab production by B cells (12).
The murine model of infection with L. major lends itself for
the study of immunity to intracellular pathogens. In this model
system, mice from most inbred strains are resistant to infection
with Leishmania major but mice from the BALB strains de-
velop progressive disease. Genetically determined resistance
and susceptibility to infection result from the appearance of
parasite-specific CD4! Th1 or Th2 cells, respectively (13).
Thus, if B cells are required for Th2 cell response in BALB/c
mice, BALB/c mice deficient in B cell should develop a Th1
response and control the infection. Indeed, there is some evi-
dence that B cells could play a role in the susceptibility to
infection with L. major. First, anti-IgM-treated BALB/c mice
control effectively their infection (14), and BALB/c Xid mice
that lack the B1 B cell subset are more resistant to infection
than controls (15). Furthermore, administration of IL-7, which
increases the number of B cells to BALB/c Xid mice, exacer-
bated the disease (16). Finally, whereas reconstitution of SCID
mice with T cells alone induced resistance to infection, addi-
tional transfer of B cells led to susceptibility to L. major (17).
*World Health Organization-Immunology Research and Training Centre, and †De-
partment of Biochemistry, University of Lausanne, Epalinges, Switzerland; and ‡Unit
of “Early responses to parasites and immunopathology,” Department of Parasitology
and Mycology, Institut Pasteur, Paris, France
Received for publication January 7, 2008. Accepted for publication January 7, 2008.
The costs of publication of this article were defrayed in part by the payment of page
charges. This article must therefore be hereby marked advertisement in accordance
with 18 U.S.C. Section 1734 solely to indicate this fact.
1 This work was supported by Grant 310000-107719 from the Swiss National Foun-
dation and by the Institut Pasteur.
2 C.R. and H.V. contributed equally to this work.
3 Current address: Protein Analysis Facility-Centre for Integrative Genomics, Le
Ge´nopode, CH1015 Lausanne, Switzerland.
4 Address correspondence and reprint requests to Dr. Pascal Launois, World Health
Organization-Immunology Research and Training Centre, University of Lausanne, Ch.
des boveresses 155, 1066 Epalinges, Switzerland. E-mail address: p.launois@unil.ch
5 Abbreviations used in this paper: DC, dendritic cell; HEL, hen egg lysozyme; Tg,
transgenic; LN, lymph node; LACK, Leishmania-activated C kinase; MFI, mean flu-
orescence intensity.
Copyright © 2008 by The American Association of Immunologists, Inc. 0022-1767/08/$2.00
The Journal of Immunology
www.jimmunol.org
Interestingly, B cells from susceptible BALB/c mice were
shown to be better Th2 inducer than B cells from resistant
C57BL/6 mice (18). However, in contrast with these data, in-
fection of mice genetically deficient in B cells with L. major
generated conflicting results. Indeed, both wild-type and
BALB/c !MT mice were equally susceptible to infection with
L. major and mounted a similar Th2 cell response (19). Fur-
thermore, in JHD mice on a BALB/c genetic background, there
was no clear evidence for a role of B cells in the development
of susceptibility to infection. Indeed, although in some reports
these mice were susceptible (20), in others these mice were
resistant (21). These discrepancies might be due to either the
genetic background of infected mice, i.e., BALB/c !MT or JHD
mice, or to the number or strains of L. major used for infection,
i.e., strains IR173, Friedlin, and WR309 L. major.
Thus, given the different patterns of diseases obtained in B cell-
deficient mice infected with L. major and the absence of clear
evidence for a role of B cells in the susceptibility of BALB/c mice
to infection, we analyzed in this study the susceptibility and T
helper responses in BALB/c !MT mice infected with L. major
from different strains. In contrast to infection with L. major strains
IR173 or IR75, B cells were necessary for susceptibility to infec-
tion with L. major LV39, and played a critical role as APCs to
instruct the development of the Th2 response observed in suscep-
tible BALB/c mice.
Materials and Methods
Mice
The !MT mice and hen egg lysozyme (HEL) transgenic (HEL Tg) MD4
mice on the C57BL/6 background were obtained from Kitamura et al. (22)
and Goodnow and colleagues (23), respectively. These mice were back-
crossed 10 times to the BALB/c background. Flow cytometry analysis
was used to confirm the absence of B220! and CD19! cells in the
peripheral blood of BALB/c !MT mice, and the expression of the HEL
Tg (IgMa) using biotinylated HEL followed by a streptavidin-FITC.
The receptor Leishmania-activated C kinase (LACK)-specific (ABLE)
TCR-transgenic mice that express a V"4-V#8 TCR recognizing an
epitope comprising the aa 156 –173 from the LACK Ag in the context
of MHC class II I-Ad molecules were provided by Dr. R. M. Locksley
(University of California, San Francisco, San Francisco, CA) (24).
DO11.10 mice, which express a transgenic TCR specific for OVA, were
obtained from The Jackson Laboratory. Female BALB/c and C57BL/6
were purchased from Harlan. Mice were bred and maintained in the animal
facilities of the Swiss Institute for Experimental Cancer Research under
pathogen-free conditions. The maintenance and care of mice complied with
the guidelines of the University of Lausanne Ethic Committee for the hu-
man care of laboratory animals.
Parasites and infection
L. major LV39 (MRHO/SU/59/P), IR173 (MHOM/IR/"173), and IR75
(MRHO/IR/75/ER) were maintained in vivo and grown in vitro as previ-
ously described (25). L. major LV39 (MRHO/SU/59/P) has been isolated
from a gerbil reservoir in southern Russia. L. major IR173 (MHOM/IR/
"173) and L. major IR75 (MRHO/IR/75/ER) have been isolated from
patients with localized cutaneous leishmaniasis in Iran. If course of infec-
tion (Fig. 1A) and parasite number (Fig. 1C) within the lesion are consid-
ered as marker for virulence, strains IR173 and IR73 L. major could be
considered as more virulent than the LV39 strain. For infection, mice were
injected in one hind footpad with 3 # 106 stationary phase L. major pro-
mastigotes in a volume of 50 !l of DMEM. Size of footpad lesions were
measured with a Vernier caliper and compared with the thickness of the
uninfected footpad. Footpad tissues were used to create limiting dilutions
for quantification of viable parasite burdens as previously described (25).
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FIGURE 1. BALB/c !MT mice control infection with L. major LV39 but not with L. major IR173 and IR75. A, BALB/c, C57BL/6, and BALB/c
!MT mice were infected with 3 # 106 L. major IR173, IR75, and LV39 in the footpad, and lesion development was monitored using a Vernier
caliper. Mean size and SD of lesions (n $ 5 mice per group) is shown. Similar results were obtained in two different experiments. B, Draining LN
from infected mice were isolated from mice described in A at the end of infection. RNA was extracted and the levels of IL-4 and IFN-$ mRNA
expression were determined by semiquantitative RT-PCR. Results are expressed as the fold increases in cytokine mRNA compared with levels in
noninfected mice from the corresponding group. Results were comparable in two independent experiments. C, The number of parasites in lesions
at the end of infection in mice designated in A was quantified as described in Materials and Methods. Similar results were obtained in two separate
experiments.
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Reagents
The Leishmania receptor for activated C kinase (LACK) and the recom-
binant LACK with the major I-Ad epitope (bp 660–713) deleted (%LACK)
were produced in Escherichia coli from the expression plasmid pET3a-
%9-rLACK and purified on Ni-NTA Sepharose as previously described
(26). HEL and OVA were purchased from Sigma-Aldrich. HEL, OVA, and
purified recombinant LACK were biotinylated with LC-NHS-biotin-EZ
linker from Pierce according to the supplier instructions. Following exten-
sive dialysis, the biotinylated molecules were mixed in a 2:2:1 molar ratio
with avidin or PE-Cy5-labeled avidin (Molecular Probes) for 60 min at
room temperature to obtain HEL-LACK, OVA-LACK, and HEL-OVA
complexes. The FITC-conjugated CD19 (1D3, IgG2a) and B220 (RA36B2,
IgG2b) mAbs were obtained from BD Biosciences and used in FACS
analysis.
MACS and adoptive transfer of B cells to BALB/c !MT mice
Naive B cells were purified from spleen cells from either naive BALB/c or
HEL Tg BALB/c mice using MACS (Miltenyi Biotec). Briefly, total spleen
cells were incubated with magnetic microbeads conjugated with anti-B220
(RA36B2) and B220! cells isolated after immobilization with a magnet.
This resulted in a cell population consisting of 97% B220! or CD19! B
cells as determined by flow cytometric analysis using FITC-conjugated
anti-B220 or anti-CD19 mAbs. BALB/c !MT mice were reconstituted
with 107 purified B cells by the i.v. route and infected with L. major 3 days
later.
Passive serum transfer
Immune serum was collected from BALB/c mice 6 wk after infection with
L. major LV39. Passive serum transfer was done by injecting BALB/c
!MT mice with immune serum i.p. using the following four different reg-
imens: 100 !l on days"6,"3, and!2; 200 !l on days!1,!7, and!14;
200 !l on day !21 of infection as previously described (21, 27); and 200
!l on days "2, 0, !2, !6, and !14.
Leishmania-specific IgG serum levels
The levels of Leishmania-specific IgG Abs in the sera of mice were ana-
lyzed by ELISA at different time points after infection of BALB/c !MT
transferred or not with immune serum. Briefly, wells of 96-well plates
(MaxiSorb; Nunc) were coated with L. major lysate (equivalent to 106
promastigotes/well) in PBS at 4°C overnight. After saturating nonspecific
binding sites with PBS-10% FCS for 2 h at 37°C, the Ag-coated wells were
probed 2 h at 37°C with individual serum samples at different dilutions in
PBS-10% FCS. Bound L. major-specific IgG Abs were detected with bi-
otinylated goat anti-mouse IgG (dilution 1/2000; Invitrogen Life Technol-
ogies) following by streptavidin-peroxidase conjugate (dilution 1/10,000;
DakoCytomation). After washing, enzyme activity was detected using the
tetramethylbenzidine substrate (Sigma-Aldrich). All samples were set up in
duplicates and the absorbance (OD & $ 450 nm) was measured using an
ELISA reader (Multiskan Ascent; Thermo LabSystems).
Lymphocyte cultures, proliferation, and detection of cytokines
in supernatants
Popliteal LN cells (5 # 106) were stimulated with UV irradiated L. major
promastigotes (1 # 106) in a final volume of 1 ml. Cells were cultured in
DMEM supplemented with 5% heat-inactivated FCS, 2 mM L-glutamine,
5 # 10"5 M 2-ME and 10 mM HEPES in an atmosphere of 7% CO2 at
37°C. Culture supernatants were collected after 72 h and stored "20°C
until use. IFN-$ was measured in supernatants by ELISA as described (28).
Mouse recombinant IFN-$ (supernatant of L1210 cells transfected with the
murine IFN-$), a gift of Y. Watanabe (Kyoto University, Kyoto, Japan),
was used as standard. IL-10 and IL-4 were measured by ELISA using a
commercial kit (BD Biosciences). The limits of detection of these assays
were 10 IU/ml for IFN-$ and 20 pg/ml for IL-4 and IL-10.
In designated experiments CD4! T cells were purified (95% of purity)
from spleen cells of ABLE or DO11.10 mice by magnetic cell sorter as
described by the manufacturer (Miltenyi Biotec). Depending of experi-
ments, 3 # 104 CD4! T cells were stimulated with either HEL, OVA,
LACK, %LACK, HEL-LACK, or OVA-LACK complexes (5 !g/ml) in the
presence as APC of either irradiated spleen cells (107) or purified B cells
(106) obtained from either BALB/c mice or HEL Tg BALB/c mice already
described. The cells were then pulsed at 48 h with 1 !Ci [3H]thymidine,
and cell proliferation assessed 18 h later.
Receptor-mediated internalization of the LACK-HEL complex
The internalization of HEL-LACK or OVA-LACK complexes by HEL Tg
B cells was analyzed by incubating total splenocytes with specific anti-Fc
receptor Ab (2.4G2) for 15 min at 4°C in PBS containing 5% FCS. Fol-
lowing washing, the cells were incubated with Cy5-labeled HEL-LACK or
Cy5-labeled OVA-LACK complex for 30 min at 4°C. Alternatively the
incubation with fluorescent complexes was performed at 37°C allowing its
internalization. Complexes bound to the cell surface were stripped by in-
cubating the cells with a buffer containing 25 mM 2-ME acid (29). B cells
were then specifically detected by staining with FITC-B220 Ab (RA36B2)
for 30 min at 4°C. The mean fluorescence intensity (MFI) for the stripping
efficiency of the complex for B220! cells was calculated as follow: (100"
(MFI of PE-Cy5 complex in B220! cells after stripping and incubation at
4°C/MFI of PE-Cy5 complex in B220! cells before stripping and incuba-
tion at 4°C))# 100. The efficiency of internalization was determined using
the following: (100 " (MFI of PE-Cy5 complex in B220! cells after strip-
ping and incubation at 37°C/MFI of PE-Cy5 complex in B220! cells be-
fore stripping and incubation at 37°C)) # the stripping efficiency. The
stripping efficiency was 88% and the internalization by HEL Tg B cells was
87% for HEL-LACK complex and &1% for OVA-LACK complex.
RNA extraction and competitive PCR
Total RNA was extracted from cells of draining LNs as described (26).
First strand cDNA synthesis was performed using a first strand cDNA
synthesis kit according to the manufacturer’s directions (Amersham Bio-
sciences). The polycompetitor plasmid pQRS was used to quantitate
amounts of transcripts for IFN-$, IL-4, and the constitutive expressed
HPRT gene, using primers and PCR conditions as previously described
(30). The first strand cDNA was used directly as a template in the presence
of serial 5-fold dilution of the pQRS competitor. After separation of the
PCR products by agarose gel electrophoresis, the ratio of IFN-$ or IL-4 to
HPRT transcripts was calculated. The results are shown as the fold in-
creases in cytokine mRNA in mice infected with L. major.
Results
B cells are required for Th2 cell maturation in BALB/c mice
infected with L. major LV39 but not with L. major IR173
and IR75
To determine whether B cells are required for susceptibility to
infection with L. major, groups of BALB/c !MT mice together
with resistant C57BL/6 and susceptible BALB/c mice were in-
fected with L. major from three different strains, i.e., IR173, IR75,
and LV39. Although disease progression with the three different
strains of L. major was similar in susceptible BALB/c and resistant
C57BL/6 mice, different patterns of infection occurred in BALB/c
!MT mice. As shown in Fig. 1A, BALB/c !MT mice infected
with L. major IR173 and IR75 expressed a susceptible phenotype
identical with BALB/c wild-type mice. In contrast, BALB/c !MT
mice infected with LV39 contained partial lesions that remained in
a plateau during the time of infection.
Levels of IL-4 and IFN-$ mRNA expression in draining LN
cells were measured at the end of the infection. Infection with L.
major IR173, IR75, and LV39 induced a Th2 response with high
levels of IL-4 in BALB/c mice and a Th1 response with low levels
of IL-4 in C57BL/6 mice (Fig. 1B). In contrast, whereas infection
with L. major IR173 and IR75 induced a Th2 response in BALB/c
!MT mice, these mice developed a Th1 response with low levels
of IL-4 after infection with L. major LV39 (Fig. 1B). Interestingly,
levels of IFN-$ were similar in BALB/c !MT and C57BL/6 mice
infected with the three different strains. IL-4 and IFN-$ mRNA
expression was confirmed by real-time PCR (data not shown).
The number of parasites in the lesions of BALB/c !MT mice
was compared with the number in control susceptible BALB/c
mice following infection with parasites from the three different
strains. After infection with L. major IR75 and IR173, parasite
numbers were similar in BALB/c !MT and BALB/c mice (Fig.
1C). In contrast, lesions from BALB/c !MT mice infected with L.
major LV39 contained an average of 1000-fold less parasites than
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BALB/c mice, indicating that parasite growth was controlled in
BALB/c !MT mice infected with L. major LV39 (Fig. 1C).
Together the results show that B cells are required for Th2 cell
response and consequently susceptibility in BALB/c mice to in-
fection with L. major LV39 but not to infection with L. major IR75
and IR173.
Adoptive transfer of naive B cells allows the expression of a
susceptible phenotype in otherwise resistant BALB/c !MT mice
infected with L. major LV39
Because BALB/c !MT mice express a partially resistant pheno-
type after infection with L. major LV39, we assessed whether the
adoptive transfer of naive B cells into BALB/c !MT before in-
fection could redirect Th2 cell development and susceptibility to
infection with L. major. Thus 107 B cells purified from the spleen
of naive BALB/c mice were injected i.v. into BALB/c !MT mice.
Three days later, B cell-reconstituted mice and control mice were
infected with L. major LV39, and the course of infection was mon-
itored. At the time of infection, LN from reconstituted mice con-
tained a mean percentage of B cells of 8.43' 4.3% compared with
15.4 ' 3.8% in control mice.
As shown in Fig. 2A, BALB/c !MT mice contained the in-
fection, whereas BALB/c !MT reconstituted with naive B cells
developed progressive lesions similar to those observed in
BALB/c mice. Estimation of the number of parasites in lesions
clearly showed that parasites were controlled in BALB/c !MT
mice but not in BALB/c !MT mice reconstituted with naive B
cells (Fig. 2B).
Analysis of the cytokine production by LN cells at the end of
infection showed that whereas BALB/c !MT mice reconstituted
with B cells developed a strong Th2 response with high levels of
IL-4 similar to the response observed in infected BALB/c mice,
BALB/c !MT mice not reconstituted with B cells developed a Th1
response with high levels of IFN-$ and very low levels of IL-4
(Fig. 2C). Similar results were obtained with B cells purified on the
basis of B220 or CD19 marker expression.
These results demonstrate that adoptive transfer of naive B cells
into BALB/c mice deficient for B cells restore their capacity to
mount a Th2 cell response and render them susceptible to infection
with L. major LV39.
Specific Abs do not promote the expression of a susceptible
phenotype in resistant BALB/c !MT mice
To determine whether the production of Abs could account for the
ability of B cells to restore susceptibility to infection with L. major
in BALB/c !MT mice, we studied the effect of injection of im-
mune serum from infected BALB/c mice on the course of disease
in BALB/c !MT mice. Immune serum was administrated to
BALB/c !MT mice either on days "6, "3, and !2 or on days !
1,!7,!14 or with L. major LV39 infection at day!21. Whatever
time of immune serum transfer before and at the first day of the
infection in !MT mice, i.e., on days "6 and "3 and on day !1,
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FIGURE 2. B cells are necessary for susceptibility of BALB/c mice to infection with L. major LV39. BALB/c !MT mice were reconstituted i.v. with 107 B
cells from naive BALB/c mice. Three days after the cell transfer, mice were inoculated with 3 # 106 L. major LV39. Similarly infected but not reconstituted
BALB/c !MT mice, BALB/c, and C57BL/6 mice were used as controls. Results were comparable in five independent infections. A, The size of the footpad lesion
from designated mice infected with L. major LV39 was monitored using a Vernier caliper as in Fig. 1. Mean size and SD of lesions is shown. B, The number of
parasites in the lesions at the end of infection in designated mice was quantified as described in Materials and Methods. !, p& 0.05, compared with BALB/c!MT
mice. C, Draining LN cells obtained at the end of infection in designated mice were stimulated with UV irradiated parasites, and after 72 h of culture, IL-4 and
IFN-$ production in supernatants was measured as described in Materials and Methods. For each determination, background levels of cytokines in supernatants
of cultures without L. major were subtracted. !, p & 0.05, compared with BALB/c !MT mice.
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only after one injection of immune serum, levels of L. major-
specific Ab in these mice were similar to levels observed in
BALB/c mice at day 40 postinfection and remained stable within
time of infection (Fig. 3). Regardless of the protocol used, the
administration of serum from infected BALB/c mice to BALB/c
!MT mice had no effect on the disease progression. Treated mice
developed lesions with the same size and kinetics than nontreated
mice (Fig. 4, A and B) and mounted a typical Th1 response with
high levels of IFN-$ and low levels of IL-4 (Fig. 4C). Similar
results were obtained in mice transferred with immune serum on
days "2, 0, !2, !6, and !14 in BALB/c !MT mice (Figs. 3 and
4D). Because a role for IL-10 in the progression of lesions after
administration of specific immune serum has been described (21),
we analyzed the IL-10 production in L. major-stimulated LN cells.
Although cells from BALB/c !MT mice produced significantly
lower levels of IL-10 than BALB/c mice, administration of im-
mune serum did not result in increased IL-10 production (Fig. 4, C
and D).
Adoptive transfer of HEL Tg B cells did not modify the
resistance of BALB/c !MT mice infected with L. major
In an attempt to evaluate in vivo the importance of L. major-spe-
cific B cells in redirecting Th2 cell development and susceptibility
to L. major of BALB/c !MT mice, B cells from HEL Tg mice
were adoptively transferred into BALB/c !MT mice before infec-
tion with L. major LV39 and the development of lesions moni-
tored. Whereas BALB/c !MT mice reconstituted with wild-type B
cells developed progressive disease and Th2 cell responses similar
to responses observed in BALB/c mice, BALB/c !MT mice re-
constituted with HEL Tg B cells developed less severe lesions and
a Th1 response (Fig. 5, A and C). Estimation of the number of
viable parasites in lesions clearly showed that in contrast to
BALB/c !MT mice reconstituted with normal B cells, BALB/c
!MT mice reconstituted with HEL Tg B cells showed control
lesion development (Fig. 5B). At the time of parasite burden de-
termination, the percentage of splenic B cells was similar in
BALB/c !MT mice reconstituted with wild-type or HEL Tg B
cells: 35.1 ' 4.1% and 42.5 ' 5.2% of lymphocytes in BALB/c
!MT reconstituted with wild-type B cells or HEL Tg B cells,
respectively.
These data suggest that L. major-specific B cells are required in
the development of the Th2 response observed in BALB/c mice
infected with L. major LV39.
The expression of a susceptible phenotype in resistant BALB/c
!MT mice following adoptive transfer of B cells pertains to the
APC capacity of the transferred B cells
It is known that the Th2 response developing in BALB/c mice
following infection with L. major is directed, at least initially,
against an immunodominant epitope of the LACK protein (Leish-
mania homolog of mammalian RACK1) (26). Thus, the necessity
of parasite-specific B cells for the induction of a Th2 response to
L. major LV39 could proceed from an advantage of B cells with
specific Ig receptors for L. major on their surface for presenting
LACK epitope to specific cells. Therefore, we compared B cells
from wild-type BALB/c mice with B cells from HEL Tg mice for
their ability to present LACK to specific T cells.
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FIGURE 3. Levels of total L. major-specific
IgG in BALB/c !MT mice after immune serum
transfer. L. major-specific IgG production in sera
of L. major-infected BALB/c !MT mice, in-
jected or not with immune serum, and control
groups over infection was measured. Results rep-
resent OD values (450 nm) of serum dilutions for
one representative mouse per group.
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The ability of B cells to present LACK was analyzed in vitro in
a proliferation assay using CD4! T cells from mice transgenic for
a TCR specific for the I-Ad-dominant epitope of LACK and ex-
pressing the V"4-V#8 TCR chains (ABLE mice). CD4! T cells
specific for OVA (DO11.10 mice), an Ag unrelated to L. major,
were used as controls.
First, we tested the specificity of the proliferation of LACK
and OVA specific CD4! T cells using irradiated BALB/c spleen
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FIGURE 4. Administration of immune serum to BALB/c !MT mice does not promote susceptibility to L. major LV39. BALB/c !MT mice were
injected i.p. with immune serum obtained from 6-wk-infected BALB/c mice at day "6, "3, and !2 (A) or days !1, !7, and !14 or at day ! 21 (B) of
infection with L. major LV39. Similarly not treated BALB/c !MT mice and BALB/c mice were used as controls. Results were comparable in three
independent experiments. A and B, The size of the footpad lesion from designated mice infected with L. major LV39 was monitored using a Vernier caliper
as in Fig. 1. Mean size and SD of lesions is shown. C, Draining LN cells obtained at the end of infection in designated mice were stimulated with UV
irradiated parasites and after 72 h of culture, IL-4, IL-10, and IFN-$ production were measured in supernatants as described in Materials and Methods. For
each determination, background levels of cytokines in supernatants of cultures without L. major were subtracted. !, p & 0.05, between with BALB/c and
BALB/c !MT mice. D, BALB/c !MT mice were injected i.p. with immune serum obtained from 6 wk infected BALB/c mice at day "2, 0, !2, !6, and
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culture, IL-4, IL-10, and IFN-$ production were measured in supernatants.
4830 B CELLS AND SUSCEPTIBILITY TO INFECTION WITH L. major
cells as source of APCs. As expected, L. major and LACK were
able to induce proliferation of LACK-specific CD4! T cells
(Fig. 6A) but not of OVA-specific CD4! T cell (Fig. 6B). Sim-
ilarly, OVA was able to induce proliferation of OVA-specific
CD4! T cells (Fig. 6B), but not proliferation of LACK-specific
CD4! T cells (Fig. 6A).
The capacity of purified B cells to present Ag was similarly
determined. B cells from BALB/c mice in the presence of L.
major and LACK induced proliferation of LACK-specific
CD4! T (Fig. 6A), but not proliferation of OVA-specific CD4!
T cells (Fig. 6B). As expected, %LACK, which is lacking the
I-Ad immunodominant epitope recognized by the LACK-spe-
cific V"4-V#8 CD4! T cells, did not induce proliferation in
either LACK-specific (Fig. 6A) or OVA-specific (Fig. 6B)
CD4! T cells. OVA was unable to induce proliferation of
LACK-specific CD4! T cells (Fig. 6A), but induced a strong
response of OVA-specific CD4! T cells (Fig. 6B). Irradiated
spleen cells and B cells from BALB/c mice and T cells alone
from either ABLE or DO11.10 mice were unable to proliferate
in response to LACK or OVA stimulation (data not shown).
Together these results demonstrated that B cells are able to
present L. major and LACK to specific CD4! T cells.
To assess the importance of the BCR specificity for presen-
tation of the LACK epitope, the proliferation of LACK- or
OVA-specific CD4! T cells in vitro in the presence of B cells
from BALB/c HEL Tg mice that express at their surface only
IgM or IgD specific for HEL was analyzed. When HEL Tg B
cells were used as APC and in contrast to wild-type B cells, no
detectable proliferation of LACK-specific CD4! T cells in re-
sponse to stimulation with L. major and LACK was observed
(Fig. 6C). In contrast, although unable to induce proliferation of
LACK-specific CD4! T cells, OVA induced a significant pro-
liferation of OVA-specific CD4! T cells in the presence of HEL
Tg B cells (Fig. 6C).
The inability of HEL Tg B cells to present LACK to specific T
cells could result from the inability of these cells to bind LACK
through their specific BCR or from another inherent defect in
LACK presentation. To distinguish between these two possibili-
ties, we constructed HEL-LACK tetrameric complexes using bio-
tinylated HEL and LACK coupled to a fluorochrome allowing
measurement of the binding and internalization of these complexes
by HEL Tg B cells. Furthermore, we assessed the capacity of HEL
Tg B cells to present LACK following HEL-LACK complex in-
ternalization and used OVA-LACK and HEL-OVA complexes as
controls.
The specific binding of the HEL-LACK complexes to HEL Tg
B cells and to B cells from wild-type BALB/c mice was investi-
gated at 4°C. Fig. 7A clearly shows that most of HEL Tg B cells
(77% as detected by B220 expression) were able to bind HEL-
LACK complex but not to OVA-LACK complex (6% of HEL Tg
B cells). In contrast, only 2–3% of B cells from BALB/c mice were
able to bind to either HEL-LACK or OVA-LACK complex. As
controls, 72% of HEL Tg B cells did bind to the HEL-OVA com-
plexes and &2% of the OVA-LACK complexes (data not shown),
thus strongly suggesting that HEL Tg B cells bind specifically to
the HEL-LACK complex.
To test whether HEL Tg B cells internalized HEL-LACK
complex, B cells were incubated at 37°C with the complexes, a
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FIGURE 5. HEL Tg B cells are unable to restore susceptibility to L. major LV39 in BALB/c !MT mice. BALB/c !MT mice were reconstituted
i.v. with 107 B cells from either normal or HEL Tg BALB/c mice. Three days after cell transfer, mice were inoculated with 3 # 106 L. major LV39.
Similarly infected but not reconstituted BALB/c !MT and BALB/c mice were used as controls. Similar results were obtained in three different
experiments. A, The size of the footpad lesion from designated mice infected with L. major LV39 was monitored using a Vernier caliper as in Fig.
1. Mean size and SD of lesions is shown. The results are from one of three experiments giving comparable results. B, The number of parasites in
the lesions of designated mice at the end of infection was estimated as described in Materials and Methods. !, p & 0.05, compared with BALB/c
!MT mice. C, Draining LN cells obtained at the end of infection in designated mice were stimulated with UV irradiated parasites as described in
Materials and Methods. After 72 h of culture, IL-4 and IFN-$ production in supernatants were measured as described in Materials and Methods.
For each determination, background levels of cytokines in supernatants of cultures without L. major were subtracted. !, p & 0.05, compared with
BALB/c !MT mice.
4831The Journal of Immunology
condition allowing their internalization, and thereafter treated
with a stripping protocol that dissociates the complex from the
cell surface. This treatment did not affect the fluorescent stain-
ing of B cells indicating that the HEL-LACK complex had been
internalized. Following incubation at 4°C, a temperature that
prevents internalization and limits the staining to the cell sur-
face, fluorescent HEL-LACK complex was stripped from the
surface (up to 88% of stripping efficiency). Thus, at 37°C, HEL
Tg B cells efficiently internalized HEL-LACK complex (Fig.
7B) as well as HEL-OVA complex (data not shown). Interest-
ingly, although some HEL Tg B cells can bind the OVA-LACK
complex (Fig. 7A), these cells are unable to internalize it (Fig. 7B).
Finally, the capacity of HEL Tg B cells to present the LACK
peptide following the internalization of HEL-LACK complex was
assessed by measuring proliferation of LACK-specific CD4! T
cells. As shown in Fig. 7C, LACK-specific CD4! T cells prolif-
erated in response to HEL-LACK complex presented by either B
cells from wild-type or HEL Tg mice. As controls, HEL-OVA
complex did not induce detectable proliferation of LACK-specific
cells but they induced, in contrast to HEL-LACK complex, strong
proliferation of OVA-specific CD4! T cells (Fig. 7C). It appears
therefore that the internalization of the LACK protein by HEL-
specific B cells renders these cells able to present LACK epitope
to specific T cells.
Together, these results suggest that the inability of HEL Tg B
cells to induce the proliferation of LACK-specific CD4! T cells is
resulting from their inability to bind and internalize LACK through
their specific BCR.
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Discussion
The influence of B cells in Th2 cell development and susceptibility
to infection with L. major was analyzed in BALB/c !MT mice that
are deficient in B cells. Results have shown that B cells are re-
quired for susceptibility and Th2 cell development in BALB/c
mice infected with L. major LV39. In contrast to BALB/c mice,
BALB/c !MT mice infected with L. major LV39 restrict the de-
velopment of lesions, contain parasites replication and mount a
Th1 response. Adoptive transfer of B cells from BALB/c mice in
B cell-deficient BALB/c !MT mice before infection redirect sus-
ceptibility to infection with L. major LV39 and Th2 cell develop-
ment in these otherwise resistant mice, implying a role of B cells
in the susceptibility to infection with this parasite. These results are
in agreement with previous data showing that although adoptive
transfer of T cells alone in SCID mice induced resistance to L.
major, transfer of T and B cells induced susceptibility (17). Note-
worthy BALB/c mice deficient in B cells are also resistant to other
Leishmania species such as L. donovani (31) or L. mexicana (27).
Remarkably, BALB/c !MT mice, although resistant to L. major
LV39, were fully susceptible to infection with L. major from two
other strains IR75 and IR173, and developed a Th2 cell response
to these parasites. It is noteworthy that contradictory data concern-
ing the outcome of infection in B cell-deficient mice have been
obtained using different strains of L. major (19, 20). In a similar
vein, opposite outcomes of infection have been also observed in
IL-4R#"/" BALB/c mice depending upon the strains of L. major
used for infection: L. major LV39 caused progressive lesions,
whereas L. major IR173 was controlled (32, 33). Moreover, there
is evidence that L. major from distinct strains have intrinsic dif-
ferences in their susceptibility to killing by immune-activated mac-
rophages in vitro. Indeed killing of LV39 by macrophages required
25- to 500-fold greater concentrations of IFN-$ than killing of
IR173 (33).
Although numerous studies attest that susceptibility of BALB/c
mice to L. major result from the maturation of Th2 responses re-
gardless of the strain of L. major used for infection, the present
study results indicate that B cells are required for Th2 cell devel-
opment only after infection with L. major LV39.
The two main functions of B cells are Ig production or Ag
presentation to T cells. Because Abs have been shown to play a
critical role in the pathology associated with infection with either
L. amazonensis (27) or L. major (21), we studied the possible role
of immune serum in restoring susceptibility to L. major LV39 in
BALB/c !MT mice. Using three different regimens of adminis-
tration of immune serum, i.e., either around the time of infection
(day "6, "2, and !3), during the first 2 wk of infection (day !1,
!7, and !14), or at day 21, we were unable to alter the course of
infection with L. major LV39 in BALB/c !MT mice and redirect
Th2 cell development. Similar results were observed using a more
stringent regimen of administration of immune serum, i.e., days
"2, 0, !2, !6, and !14 (data not shown). IL-10 produced by
macrophages in response to the ligation of specific Abs to Fc$R
(21, 34) has been recently reported to exacerbate the disease pro-
gression (21). Contrasting with these results, we were unable to
detect IL-10 production by L. major-stimulated LN cells from
BALB/c !MT mice treated with immune serum. Thus, our present
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FIGURE 7. The failure of HEL Tg B cells to present LACK to specific
T cells results from their inability to internalize LACK. A, Binding of the
HEL-LACK complex to specific HEL Tg B cells was analyzed by incu-
bating Cy5-labeled HEL-LACK complex with spleen cells from either wild
type or HEL Tg BALB/c mice. Cy5-labeled OVA-LACK complex was
used as controls. B cells were stained with FITC-conjugated anti-B220 Ab
as described in Materials and Methods. Results are from one of three
experiments with comparable results. B, After incubation of Cy5-labeled
HEL-LACK complexes with total splenocytes from HEL Tg BALB/c mice
at either 4 or 37°C, the complexes bound to the cell surface were stripped
by incubation with 2-ME as described in Materials and Methods. The
presence of HEL-LACK-Cy5 was analyzed on gated B cells stained with
FITC-conjugated anti-B220 mAb. Gray line: florescence before stripping.
Bold line: fluorescence after stripping. Results are from one of three ex-
periments giving similar results. C, CD4! T cells from spleen from ABLE
mice (LACK-specific T cells) and from D11.10 mice (OVA-specific
T cells) were purified by MACS. A total of 3 # 104 purified CD4! T cells
were stimulated in the presence of HEL-LACK or HEL-OVA complexes
(5 !g/ml) and of purified B cells (106) from wild-type or HEL Tg BALB/c
mice. The cells are pulsed at 48 h with 1 !CI [3H]thymidine and cell
proliferation assessed 18 h later. Results are presented as mean and SD of
triplicates and are from one of three experiments with comparable results.
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data clearly differ from previous findings showing that specific Ig
contribute to susceptibility to infection with L. major (21) and L.
amazonensis (27). Because in the reports showing an effect of
specific Abs on the course of disease, amastigotes were used for
infection, these discrepancies could be due to the use of promas-
tigotes in our study. The internalization of promastigotes by host
cells occurs mainly through the mannose fucose receptor, the fi-
bronectin receptor, and CR1 and CR3 complement receptors (35).
In contrast, Ig coated on tissue-derived amastigotes (36) may mod-
ulate the uptake of amastigotes by macrophages and induce IL-10
production (21). Nevertheless, supplying immune serum at day 21
after infection in BALB/c !MT mice, a time when the amastigote
differentiation has occurred, did neither modify the progression of
lesion nor redirected Th2 cell development. Thus, under the con-
ditions used in this study, specific Igs are not responsible for the
effect of adoptively transferred B cells on the course of disease in
BALB/c !MT mice.
The possible role of B cells in T cell activation is controversial.
Indeed, T cells proliferation from B cell-deficient mice has been
shown to be either normal (10–12) or lower than in control
BALB/c mice (7, 37–39). Results in this report show that, in vitro,
CD4! T cells specific for LACK, an Ag from Leishmania, prolif-
erate in the presence of B cells. Noteworthy, LACK-specific CD4!
T cells failed to proliferate in the presence of monoclonal B cells
from HEL Tg mice that express at their surface only IgD/IgM
specific for HEL, which is an irrelevant Ag. These results suggest
that the presence of B cells with specific Ig receptors for either
LACK or L. major within the population of B cells used as APC
was required for the activation of LACK-specific CD4! T cells.
Indeed allowing LACK to bind to the receptors of HEL-specific B
cells by using an engineered HEL-LACK construct, enable these
cells to specifically stimulate LACK-reactive CD4! T cells. These
results combined with the observations showing that reconstitution
of BALB/c !MT mice with HEL Tg B cells, in contrast to wild-
type B cells, neither redirect Th2 development nor susceptibility to
L. major, indicating that promotion of Th2 cell development by B
cells requires cognate interactions between these cells. In contrast,
the presence of B cells with a specific receptor for OVA is not
required for the activation of OVA-specific CD4! T cells. Indeed
and as already described (40), OVA-specific CD4! T cells were
able to proliferate in the presence of B cells from wild-type or HEL
Tg mice. Unfortunately, using biotinylated LACK, we were unable
to detect LACK-specific B cells in B cells from naive BALB/c
mice, suggesting that the frequency of LACK-specific B cells is
rather low as determined by FACS analysis (data not shown). The
frequency of B cells with a given specificity has been estimated to
be 1 of 4 # 104 naive B cells (41). However, only five activated
B cells are required for the formation of germinal centres within 6
to 7 h after Ag administration (42), demonstrating that few B cells
are sufficient to induce a response. Remarkably, it has recently
been reported that Ag-specific B cells residing in the follicles ac-
quire Ag within minutes of injection first in the region closest to
the subcapsular sinus where lymph enters the LN. Subsequent T
cell activation did not appear to require B cell migration to T cell
area (43).
It is well established that IL-4 provides an important signal for
Th2 differentiation and susceptibility to infection with L. major
(44). Because production of IL-4 by B cells has been reported (45),
some IL-4 derived from Leishmania-activated B cells might play a
role in instructing Th2 cell differentiation. However, we were un-
able to detect IL-4 either in vitro in L. major stimulated B cells or
ex vivo in purified B cells at different times after infection (data not
shown), suggesting that the role of B cells in favoring the devel-
opment of a Th2 cell response during infection with L. major is not
due to the IL-4 they could produce but rather to other signals
instructing T cells to produce IL-4 (6, 46, 47). In this context, it has
been recently shown that during infection with Nippostrongylus
brasiliensis that the expression of B7-1/B7-2 on B cell is involved
in the development of the B cell-dependent Th2 immune response
rather than B cell-derived IL-4 (48). Our present data showing that
L. major-stimulated T cells from BALB/c !MT mice infected with
L. major LV39 produced low levels of IL-4 and that adoptive
transfer of syngeneic B cells from BALB/c mice in BALB/c !MT
mice restored high levels of IL-4 strongly support a role for B
cells in the T cell-derived IL-4 production detected in suscep-
tible mice. Interestingly, such treatment had no effect on the
IFN-$ production.
The molecular basis for the role of B cells in the Th2 cell de-
velopment following infection with L. major is yet unknown. B
cells could be necessary for either initiation of T cell responses (7,
9, 49) or clonal expansion of activated T cells (50, 51). In this
context, it is admitted that DCs are essential for initiating a T cell
response. However, B cells that are the most abundant MHC class
II-positive cells within naive LNs might also play this role. It has
been reported that in vivo DCs could concentrate, transport, and
transfer Ags to naive B cells (52). Furthermore it has been recently
shown that B cells could be activated by Ag-bearing DCs through
direct membrane interaction as soon as 3 h after immunization and
thus possibly influence the T cell responses (53). Visualizing B and
T cells interactions in LN, it has been observed that Ag-specific B
cells move to the edge of the follicles very rapidly after immuni-
zation and present Ag to specific CD4! T cells that have been
activated by DCs 2 days after Ag administration (54). However, a
role of B cells in the initiation of the response could not be ex-
cluded in this study because whether the CD4! T cells were
primed during their encounter with DCs or with Ag-specific B
cells was not addressed. In this context, in a recent study, Ag
acquisition by specific B cells did not appear to require exposure
to DCs (43). Thus, although we cannot completely exclude a role
of B cells in the initiation of the response induced during infection
with L. major, B cells may have mainly a role in the maintenance
of the CD4! T cell response. Indeed, if the role of DCs is to initiate
the immune response, the capacity of DCs to sustain CD4 re-
sponses should be limited in time because it is believed that after
interaction with lymphocytes, DCs die by apoptosis (55). Further-
more, DCs exit LN 48 h after stimulation (56) leaving activated B
cells in large numbers in LN as compared with DCs.
The results presented in this study clearly indicate that B cells
are required for polarization of the Th2 cell response and suscep-
tibility to infection with L. major LV39. Full understanding of the
various parameters of this response might be important for the
design of new strategies to prevent pathology during infection with
Leishmania.
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